These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8795441)

  • 1. Renal metabolism and effects of the glutamyl derivatives of L-dopa and 5-hydroxytryptophan in man.
    Li Kam Wa TC; Freestone S; Samson RR; Johnston NR; Lee MR
    Clin Sci (Lond); 1996 Aug; 91(2):177-85. PubMed ID: 8795441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. gamma-L-glutamyl-5-hydroxy-L-tryptophan, but not gamma-L-glutamyl-L-tryptophan, causes sodium retention in normal man.
    Li Kam Wa TC; Freestone S; Samson RR; Johnson NR; Lee MR
    Br J Clin Pharmacol; 1996 Sep; 42(3):365-70. PubMed ID: 8877028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the renal and neuroendocrine effects of two 5-hydroxytryptamine renal prodrugs in normal man.
    Li Kam Wa TC; Freestone S; Samson RR; Johnson NR; Lee MR
    Clin Sci (Lond); 1993 Nov; 85(5):607-14. PubMed ID: 8287650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of gamma-L-glutamyl-L-dopa on phosphate excretion.
    Sadiq S; Berndt TJ; Nath KA; Knox FG
    J Lab Clin Med; 2000 Jan; 135(1):52-6. PubMed ID: 10638694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the renal actions of gamma-L-glutamyl-L-dopa and gamma-L-glutamyl-L-tyrosine in normal man.
    Jeffrey RF; MacDonald TM; Lee MR
    Clin Sci (Lond); 1988 Jan; 74(1):37-40. PubMed ID: 3123118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. gamma-L-glutamyl-L-DOPA inhibits Na(+)-phosphate cotransport across renal brush border membranes and increases renal excretion of phosphate.
    de Toledo FG; Thompson MA; Bolliger C; Tyce GM; Dousa TP
    Kidney Int; 1999 May; 55(5):1832-42. PubMed ID: 10231445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renal handling of dopamine originating from L-dopa and gamma-glutamyl-L-dopa.
    Pestana M; Soares-da-Silva P
    Br J Pharmacol; 1994 Jun; 112(2):417-22. PubMed ID: 8075859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of carbidopa and indomethacin on the renal response to gamma-L-glutamyl-L-dopa in normal man.
    Jeffrey RF; MacDonald TM; Marwick K; Lee MR
    Br J Clin Pharmacol; 1988 Feb; 25(2):195-201. PubMed ID: 3129006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood and urine 5-hydroxytryptophan and 5-hydroxytryptamine levels after administration of two 5-hydroxytryptamine precursors in normal man.
    Wa TC; Burns NJ; Williams BC; Freestone S; Lee MR
    Br J Clin Pharmacol; 1995 Mar; 39(3):327-9. PubMed ID: 7619676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The renal and haemodynamic effects of a 10 h infusion of glutamyl-L-dopa in normal man.
    MacDonald TM; Jeffrey RF; Lee MR
    Br J Clin Pharmacol; 1989 Jun; 27(6):811-22. PubMed ID: 2527048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, bioavailability, metabolism, tissue distribution and urinary excretion of gamma-L-glutamyl-L-dopa in the rat.
    Cummings J; Matheson LM; Maurice L; Smyth JF
    J Pharm Pharmacol; 1990 Apr; 42(4):242-6. PubMed ID: 1974290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (+)-sulpiride antagonises the renal effects of gamma-L-glutamyl-L-dopa in man.
    MacDonald TM; Jeffrey RF; Freestone S; Lee MR
    Br J Clin Pharmacol; 1988 Feb; 25(2):203-12. PubMed ID: 3129007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of noradrenaline spillover by the dopamine prodrug gamma-L-glutamyl-L-dopa: a central effect?
    McGrath BP; Wang ZQ; Shimizu K; Way D; Secombe J
    Hypertens Res; 1995 Jun; 18 Suppl 1():S113-8. PubMed ID: 8529039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of gamma-glutamyl levodopa (gludopa) after intravenous bolus injection in healthy volunteers.
    Boateng YA; Barber HE; MacDonald TM; Petrie JC; Lee MR
    Br J Clin Pharmacol; 1991 Apr; 31(4):419-22. PubMed ID: 1904753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the effects of two putative 5-hydroxytryptamine renal prodrugs in normal man.
    Li Kam Wa TC; Freestone S; Samson RR; Johnston NR; Lee MR
    Br J Clin Pharmacol; 1993 Jul; 36(1):19-23. PubMed ID: 7690583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced urinary excretion of dopamine and metabolites in chronic renal parenchymal disease.
    Pestana M; Jardim H; Serrão P; Soares-da-Silva P; Guerra L
    Kidney Blood Press Res; 1998; 21(1):59-65. PubMed ID: 9661138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Method for the determination of gamma-L-glutamyl-L-dihydroxyphenylalanine and its major metabolites L-dihydroxyphenylalanine, dopamine and 3,4-dihydroxyphenylacetic acid by high-performance liquid chromatography with electrochemical detection.
    Cummings J; Matheson LM; Smyth JF
    J Chromatogr; 1990 Jun; 528(1):43-53. PubMed ID: 2117019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympatho-inhibitory effects of r-l-glutamyl-l-dopa in conscious rabbits.
    Wang ZQ; Shimizu K; Way D; Secombe J; McGrath BP
    Zhongguo Yao Li Xue Bao; 1994 Jan; 15(1):17-21. PubMed ID: 8010078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial acute effects of selective modulation of renal dopamine system by gamma-L-glutamyl-L-dopa in rabbits with congestive heart failure.
    Wang ZQ; Way D; Shimizu K; Fong F; Trigg L; McGrath BP
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):1004-11. PubMed ID: 7687706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Domperidone treatment in man inhibits the fall in plasma renin activity induced by intravenous gamma-L-glutamyl-L-dopa.
    Worth DP; Harvey JN; Brown J; Worral A; Lee MR
    Br J Clin Pharmacol; 1986 May; 21(5):497-502. PubMed ID: 3087398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.